CHI3L2 and breast cancer: In our other study that included 68 female patients with BC (Russian cohort) who received anthracycline-containing NAC, the absence of clinical response is associated with the presence of M2+ macrophage phenotype (YKL-39-CCL18+ or YKL-39+CCL18−) (20).